Telix Pharmaceuticals Financials

Values in thousands	2026-06-30	2025-12-31	2025-06-30	2024-12-31
Revenue	$691,361	$620,440	$593,111	$594,244
Gross Profit	356,625	327,423	288,342	385,797
EBITDA	17,295	28,924	8,905	82,781
EBIT	-19,908	11,034	-1,762	78,461
Net Income	55,514	-7,252	-3,482	38,239
Net Change In Cash	691,361	620,440	593,111	594,244
Free Cash Flow	5,896	-92,598	16,836	-5,684
Cash	363,632	212,529	317,837	710,346
Basic Shares	356,890	338,778	337,202	345,188

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$1,205,426	$783,207	$502,547	$160,096
Gross Profit	640,230	509,678	314,390	94,926
EBITDA	79,831	98,233	22,966	-92,837
EBIT	47,166	92,547	16,223	-98,216
Net Income	-10,685	49,919	5,211	-104,079
Net Change In Cash	1,205,426	783,207	502,547	160,096
Free Cash Flow	-82,795	28,707	14,205	-71,008
Cash	212,529	710,346	123,237	116,329
Basic Shares	337,880	345,188	323,710	310,644